Global Portable Immunoassay Analyzer Market, By Product (Chemiluminescence Immunoassay, Immunofluorescence Analyzers, Radioimmunoassay, Enzyme-Linked Immunoassay, Consumables and Accessories), Application (Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Disease), End User (Hospitals, Diagnostic Laboratories, Research Institutes, Others) – Industry Trends and Forecast to 2030.
Portable Immunoassay Analyzer Market Analysis and Size
The growing demand for immunoassays to diagnose and detect microorganism-based infections is driving the portable immunoassay analyzer market. Also accelerating market growth are the various diseases associated with increasing need for controlling and suppressing major diseases, constantly growing incidence of chronic disease conditions such as cancer and autoimmune disorders, increasing geriatric population, changing lifestyle with growing habit of smoking and drinking, and escalating healthcare spending.
Data Bridge Market Research analyses that the portable immunoassay analyzer market which was USD 7.5 billion in 2022, is expected to reach USD 12.41 billion by 2030, at a CAGR of 6.50% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Portable Immunoassay Analyzer Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Chemiluminescence Immunoassay, Immunofluorescence Analyzers, Radioimmunoassay, Enzyme-Linked Immunoassay, Consumables and Accessories), Application (Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Disease), End User (Hospitals, Diagnostic Laboratories, Research Institutes, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Abbott (U.S.), Beckman Coulter, Inc (U.S.), bioMérieux (France), Siemens Healthcare GmbH (Germany), Biokit S.A. (Spain), DiaSorin S.p.A. (Italy), Ortho Clinical Diagnostics (U.S.), Tosoh India Pvt. Ltd. (Japan), Sysmex Corporation (Japan), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (Japan), Johnson & Johnson Private Limited (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Danaher (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Immunoassay analyzers use immunoassay methodologies such as immunoprecipitation, particle immunoassays, immunonephelometry, radioimmunoassay, enzyme immunoassay, fluorescent immunoassay, and chemiluminescent immunoassays to detect and quantify specific analytes in blood or body fluid samples. Immunoassay analyzers comprise an autosampler, a washer, a reagent dispenser, and a detection system weighing between 10 and 60 kg and weighing 600 x 750 x 1,000 mm.
Global Portable Immunoassay Analyzer Market Dynamics
Drivers
- Increasing demand for rapid and accurate diagnostics
Due to the rising demand for precise and quick diagnostics, the global market for portable immunoassay analyzers is anticipated to expand at the highest CAGR during the forecast period. This is mainly due to the increasing incidence of infectious diseases and other health conditions that require an early diagnosis for effective treatment. These are the certain factors that propel the growth of the market.
- Technological advancements
The development of novel portable immunoassay analyzer assays has led to the introduction of advanced CLA systems, which are more specific, sensitive and user-friendly than traditional methods. This is likely to boost the adoption of CLA systems in clinical laboratories worldwide.
- Growing awareness about early disease detection
People are becoming more aware of the importance of early disease detection and its impact on treatment outcomes. This is driving them to use diagnostic tests such as chemiluminescence assays for earlier diagnosis and better management of their medical conditions.
Opportunities
- Rising usage of chemiluminescence immunoassay (CLIA)
The market is seeing a significant shift away from the traditional ELISA method and toward the use of CLIA. Disease complications have increased the need to detect smaller target molecules, leading to the emergence of CLIA. It is used in conjunction with a directly labelling antigen (antibody) and an indicator such as luminol, isoluminol, or an acridinium ester. The higher sensitivity and accuracy of chemiluminescence immunoassay (CLIA) over enzyme-linked immunosorbent assay (ELISA) is expected to drive market growth prospects.
Restraints/Challenges
- Affordability of diagnostic test
Dearth of availability and affordability of diagnostic test in developing countries will obstruct market growth. Another limitation to consider is lot-to-lot variability, which is a problem with all assays. The variability of raw materials used in the formulation of the reagents can cause lot-to-lot differences in the reagents. This can have an effect on the assay's quality and must be thoroughly investigated. However, the response of certain reagents can vary from lot to lot, it is critical to check for lot-to-lot differences in calibrations and controls.
This portable immunoassay analyzer market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the portable immunoassay analyzer market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on the Portable Immunoassay Analyzer Market
The outbreak of the COVID-19 pandemic, public health experts emphasised testing, tracking infected people, and tracing their contacts as an effective strategy for containing the virus's spread. Several diagnostic methods are used in clinical, research, and public health laboratories to detect the SARS-CoV-2 virus. Antibodies against SARS-CoV-2 are measured using immunoassays. Pre-existing medical conditions, such as cardiovascular and respiratory illnesses, have been linked to an increased risk of COVID-19-related death. In addition, researchers discovered that only 9% of original cases were responsible for 80% of infections detected in close contacts. As a result, detecting the disease early is critical to help prevent its spread.
Global Portable Immunoassay Analyzer Market Scope
The portable immunoassay analyzer market is segmented on the basis of product, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Chemiluminescence Immunoassay
- Immunofluorescence Analyzers
- Radioimmunoassay
- Enzyme-Linked Immunoassay
- Consumables and Accessories
Application
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Disease
End User
- Hospitals
- Diagnostic Laboratories
- Research Institutes
- Other
Portable Immunoassay Analyzer Market Regional Analysis/Insights
The portable immunoassay analyzer market is analyzed and market size insights and trends are provided by country, product, application and end user as referenced above.
The countries covered in the portable immunoassay analyzer market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the portable immunoassay analyzer market due to the commercial availability of products, advanced technologies, and the high adoption rate of the products in the region.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to the growing technological developments and high usage of immunoassay testing for various applications.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The portable immunoassay analyzer market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for portable immunoassay analyzer market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the portable immunoassay analyzer market. The data is available for historic period 2011-2021.
Competitive Landscape and Portable Immunoassay Analyzer Market Share Analysis
The portable immunoassay analyzer market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to portable immunoassay analyzer market.
Some of the major players operating in the portable immunoassay analyzer market are:
- Abbott (U.S.)
- Beckman Coulter, Inc (U.S.)
- bioMérieux (France)
- Siemens Healthcare GmbH (Germany)
- Biokit S.A. (Spain)
- DiaSorin S.p.A. (Italy)
- Ortho Clinical Diagnostics (U.S.)
- Tosoh India Pvt. Ltd. (Japan)
- Sysmex Corporation (Japan)
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (Japan)
- Johnson & Johnson Private Limited (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Danaher (U.S.)
SKU-